Avicenna.AI announced today that it received FDA 510(k) clearance and CE mark for its Cina Chest vascular condition triage system.
Marseille, France-based Avicenna.AI designed Cina Chest to leverage deep learning algorithms to offer automatic detection and triage capabilities for both pulmonary embolism (PE) and aortic dissection (AD) from CT-scan imaging, according to a news release.
Cina Chest offers rapid, automatic PE detection on CT chest angiography with accurate and real-time alerts, while it identifies acute AD cases that require urgent intervention on thoraco-abdominal CT angiography.
“At Avicenna, we specialize in the development of AI algorithms that can identify acute abnormalities, and Cina Chest is the latest application we’ve developed to enhance emergency room radiology,” Avicenna.AI co-founder & CEO Cyril Di Grandi said in the release. “Our PE and AD triage tools are the third and fourth algorithms we’ve released in less than 12 months, demonstrating our ambition to create AI applications that support detection and triage of emergencies throughout the entire body.”